Published in
Taylor and Francis Group, Acta Oncologica, 9(59), p. 1028-1035, 2020
DOI: 10.1080/0284186x.2020.1759826
Links
Tools
The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma – a substudy of the SORAMIC trial
Journal article published in 2020 by
Tim A. Labeur 
,
Quincy Hofsink,
R. Bart Takkenberg,
Otto M. van Delden,
Ron A. A. Mathôt ,
Regina Schinner ,
Peter Malfertheiner ,
Holger Amthauer ,
Kerstin Schütte ,
Bristi Basu ,
Christiane Kuhl ,
Julia Mayerle ,
Jens Ricke ,
Heinz-Josef Klümpen
,
Quincy Hofsink,
R. Bart Takkenberg,
Otto M. van Delden,
Ron A. A. Mathôt ,
Regina Schinner ,
Peter Malfertheiner ,
Holger Amthauer ,
Kerstin Schütte ,
Bristi Basu ,
Christiane Kuhl ,
Julia Mayerle ,
Jens Ricke ,
Heinz-Josef Klümpen
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 